http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016292386-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ea51897ec80c44bb6d7978b1b532049
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60
filingDate 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d626d1d9e872283850fef20de4b35ce7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_462ab9a3a713f479f3383d2ec863352f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_736286871bdf7ff2b78b1257cde8d21e
publicationDate 2016-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2016292386-A1
titleOfInvention Systems and architecture for electronic interfaces and complex data structures for medication reconciliation and patient regimen adherence detection
abstract Optical interference filters associated with specific, unique signatures are applied to medical consumables in order to label them. The interactions of those optical interface filters with electromagnetic waves can be observed in order to determine those unique signatures. These unique signatures can be used to look up entries in a database that contain information associated with the tagged medical consumable, allowing for the medical consumable to be easily identified and verified. Various systems and methods are provided herein that utilize these optical interference filters for performing medication reconciliation and tracking patient compliance to prescribed drug schedules, which can greatly reduce the errors and costs associated with medication reconciliation and monitoring patient compliance.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11094407-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11664103-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023012636-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10847258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022129819-A1
priorityDate 2015-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014014913-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014278508-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261

Total number of triples: 29.